units

PAC4451

Faculty of Pharmacy and Pharmaceutical Sciences

Undergraduate - Unit

This unit entry is for students who completed this unit in 2012 only. For students planning to study the unit, please refer to the unit indexes in the the current edition of the Handbook. If you have any queries contact the managing faculty for your course or area of study.

print version

6 points, SCA Band 0 (NATIONAL PRIORITY), 0.125 EFTSL

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered, or view unit timetables.

LevelUndergraduate
FacultyFaculty of Pharmacy and Pharmaceutical Sciences
OfferedSunway First semester 2012 (Day)
Parkville First semester 2012 (Day)
Coordinator(s)Dr David Manallack (Parkville); Mr David Chong (Sunway)

Synopsis

This unit aims to provide the foundations for the management of dermatological conditions including patients who have wounds. It also covers the principles of

  • pain pathways
  • pain management for pain arising from a variety of sources and
  • management of musculoskeletal disorders - rheumatoid arthritis, osteoarthritis arthritis and gout.

The chemistry, pharmacology and clinical aspects of medications associated with pain management are presented in detail in an integrated fashion.
Drug therapy principles for particular conditions and patient groups will be emphasized enabling students to acquire the skills necessary to provide clinical pharmacy services within these areas.
Students will perform a number of tasks that will help foster the development of critical thinking and oral and written communication skills, leadership and teamwork.

Outcomes


  1. The pathophysiology of pain and a range of musculoskeletal and dermatological conditions (including wounds);
  2. Skin structure and skin pathology;
  3. The signs and symptoms associated with a range of musculoskeletal and dermatological conditions (including wounds);
  4. The chemistry of the different classes of drugs used in the management of these disorders;
  5. The concepts of structure-activity relationships for the drugs used in the management of these disorders;
  6. The pharmacology of the drugs used in the management of these disorders;
  7. The pharmacology and pathways associated with nociception;
  8. The signs and symptoms, emphasising cardinal symptoms, of many conditions associated with these areas.
  9. Current best practice for the management of pain and musculoskeletal conditions, including drug and non-drug therapies, with emphasis on the role of the pharmacist.
  10. Current best practice for the management common dermatological and acute and chronic wounds, including drug and non-drug therapies, with emphasis on the role of the pharmacist.
  11. Individual differences which may occur in these disorders and how they can be managed.

Assessment

Mid-semester tests (online): 5%; problem-based tutorials: 20%; final exam: 75%

Chief examiner(s)

David Manallack

Contact hours

72 hours of directed learning per semester

Additional information on this unit is available from the faculty at:

http://www.monash.edu.au/muso/support/students/index.html